Bell Gully
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
'Very easy to work with, and always thorough and diligent', Bell Gully acts on disputes across corporate, banking and finance, regulatory, insolvency, and class action matters. Sophie East co-leads the team, focusing on commercial disputes, class actions, and banking and finance litigation, including regulatory investigations. Kirsty Dobbs co-leads and advises public and private sector clients on complex disputes. Tim Fitzgerald specialises in insolvency and regulatory matters. Jesse Wilson handles corporate, construction, contractual, class action, product liability, and competition disputes. Blair Keown focuses on financial markets, regulatory proceedings, and complex commercial investigations.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Sophie East is the best big-firm litigator in New Zealand, with Sam Hiebendaal, Jesse Wilson, Brad Ward, and Alix Boberg also highly regarded.'
- 'Bell Gully has the strongest litigation practice in Auckland, engaged on most major proceedings with the deepest partner bench in the market.'
Key clients
- 3A Composites Air New Zealand ANZ Bank Ara Poutama Aotearoa Department of Corrections ASB Bank Auckland Council City Rail Link AWN Holdings Limited Calibre Partners Cigna Life Insurance Downer Group NZ Electricity Authority The Fletcher Construction Company Frucor Suntory NZ Genesis Energy IAG New Zealand INEOS Industries Holdings Johnson & Johnson Kāinga Ora Nova Energy NZ Transport Agency Waka Kotahi NZME One NZ Pharmac Port Marlborough PricewaterhouseCoopers Quanex Corporation Salvation Army Shundi Customs Stride Property Suncorp Group Synlait Milk Te Pūkenga Te Rūnanga o Ngāi Tahu Xero
Work highlights
Acting for Johnson & Johnson (New Zealand Limited), JNTL Consumer Health (New Zealand) Limited, and Johnson & Johnson Pacific Pty Limited to defend class action proceedings in relation to the efficacy of a number of Johnson & Johnson branded cold and flu medications.